Inari Medical Q2 EPS $0.04 Beats $(0.14) Estimate, Sales $119.00M Beat $116.28M Estimate
Portfolio Pulse from totan@benzinga.com
Inari Medical (NASDAQ:NARI) reported Q2 earnings of $0.04 per share, beating the analyst consensus estimate of $(0.14) by 128.57%. The company also reported quarterly sales of $119.00 million, beating the analyst consensus estimate of $116.28 million by 2.34%. This represents a 121.05% increase in earnings and a 28.32% increase in sales compared to the same period last year.
August 04, 2023 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Inari Medical's Q2 earnings and sales beat estimates, indicating a strong financial performance. This could potentially lead to a positive impact on the company's stock price.
Inari Medical reported better than expected Q2 earnings and sales, which is typically a positive signal for investors and can lead to an increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100